Home›Stock Screener›Ortin Global

Ortin Global Share Price Today | Stock Price & Ortin Global Share Screener

ORTINGLOBE Pharmaceuticals & Biotechnology
Live Share Price NSE
₹13.00
▼ -0.28 (-2.11%)
2026-11-18 00:00:00
Live Share Price BSE
₹13.77
▲ 1.14 (9.03%)
2026-11-18 00:00:00

As of November 18, 2026, the live Ortin Global share price (NSE: ORTINGLOBE) is ₹13.00 on NSE and ₹13.77 on BSE, down 2.11% from the previous close, with shares trading between ₹12.63 and ₹13.60 in today's trading session, and a 52-week range of ₹11.55–₹19.92. Track ORTINGLOBE market value to gauge the company's total market size. Use the Ortin Global stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Ortin Global opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Ortin Global Market Cap ₹10.41 Cr.
ORTINGLOBE P/E Ratio (TTM) -15.20
Ortin Global P/B Ratio 16.12
EPS (TTM) ₹-0.91
Dividend Yield -
Debt to Equity 0.39
ORTINGLOBE 52 Week High ₹19.92
Ortin Global 52 Week Low ₹11.55
Operating Margin -5.00%
Profit Margin -
ORTINGLOBE Revenue (TTM) ₹13.00
EBITDA ₹-1.00
Net Income -
Total Assets ₹5.00
Total Equity ₹1.00

Ortin Global Share Price Chart

Track the current stock price of Ortin Global with an interactive chart. Analyse ORTINGLOBE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Ortin Global stock quote in one place.

The quote of ₹13.00 sits between the 52-week low of ₹11.55 and the 52-week high of ₹19.92, and the latest session moved -2.11% from the previous close.

Ortin Global Company Profile - Fundamental Screener

Screen Ortin Global company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ORTINGLOBE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE749B01020.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE749B01020

Ortin Global Balance Sheet Screener

Screen ORTINGLOBE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹5, up from ₹4 in 2025.

Latest statistics put total assets at ₹5 and shareholder funds at ₹1, with a leverage ratio of 0.39.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 5 4 7 21 21 21 117 105 74 62
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 0 0 0 14 14 14 23 21 20 21

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1 0 2 3 2 2 9 8 8 8
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 1 2 3 11 11 11 24 25 24 23
Share Capital 8 8 8 8 8 8 17 17 17 17
Reserves & Surplus -7 -6 -5 3 3 3 7 8 7 7

Ortin Global Income Statement Screener - Profit & Revenue Analysis

Screen Ortin Global income statement and profit fundamentals. Analyze ORTINGLOBE quarterly results. Ortin Global reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2012-Jun, revenue was ₹13 and net profit was ₹0, equal to earnings per unit of ₹0.26, at an operating margin of -5%.

In that period expenses were ₹14, interest cost ₹1 and tax ₹0. The next period listed, 2012-Mar, shows revenue of ₹18 and net profit of ₹-2.

Item 2012-Jun 2012-Mar

Revenue and Expenses

Revenue 13 18
Expenses 14 21

Operating Costs and Margins

EBITDA -1 -3
Operating Profit % -5.00% -19.00%
Depreciation 0 0
Interest 1 1

Profit and Earnings

Profit Before Tax 1 -2
Tax 0 0
Net Profit 0 -2
EPS 0.26 -1.13

Ortin Global Cash Flow Screener - Liquidity Fundamentals

Screen ORTINGLOBE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹1.

Over the same period, investing activities provided ₹0 and financing activities provided ₹1.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -1 0 -5 0 2 18 3 7 2 2
Investing Activities 0 0 12 0 0 0 -3 -3 -1 -1

Financing and Net Cash

Financing Activities 1 0 -4 1 -1 -10 -1 -3 0 -1
Net Cash Flow 0 0 4 1 2 8 -1 0 1 0

Ortin Global Shareholding Pattern Screener

See Ortin Global shareholding pattern with promoter, FII, and DII holdings. Check Ortin Global promoter holding and ownership changes for ORTINGLOBE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 1.23%, foreign institutions 1.68%, domestic institutions 0.00% and the public 91.18%, spread across 11,452 shareholders.

The shareholder count was 11,452 in 2026-Mar, compared with 11,383 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 1.23% 1.23% 1.24% 1.23% 1.23% 1.23% 1.23% 1.23%

Institutional Investors

FII Holding 1.68% 1.80% 0.67% 6.53% 6.53% 1.68% 1.68% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 91.18% 90.87% 91.13% 85.32% 85.66% 90.85% 91.01% 92.04%
Other Holding 5.90% 6.10% 6.96% 6.92% 6.58% 6.23% 6.08% 6.73%
Shareholder Count 11,452 11,383 10,983 12,144 12,034 12,060 11,834 12,192

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Ortin Global. Ortin Global dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Ortin Global.

Ortin Global Stock Index Membership - Nifty & Sensex

See which indices include Ortin Global stock. Check ORTINGLOBE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Ortin Global is not part of any tracked indices.
Only major market indices are tracked in our system.

Ortin Global Market Events Screener - Corporate Actions

Get Ortin Global corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Ortin Global stock events that may affect ORTINGLOBE share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 11, 2026, with a record date of November 11, 2026.

It is followed by Annual General Meeting dated September 30, 2026 and Quarterly Result Announcement dated August 14, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-11 2026-11-11 Quarterly Result Announcement NA 1.30%
2026-09-30 2026-09-30 Annual General Meeting NA -2.26%
2026-08-14 2026-08-14 Quarterly Result Announcement NA 4.92%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 1.17%
2026-02-14 2026-02-14 Quarterly Result Announcement NA 20.05%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 4.13%
2025-09-30 2025-09-30 Annual General Meeting NA -13.38%
2025-08-25 2025-08-25 Extraordinary General Meeting NA -9.94%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -22.74%
2025-05-26 2025-05-26 Quarterly Result Announcement NA -1.86%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -5.59%
2024-11-13 2024-11-13 Quarterly Result Announcement NA -2.23%
2024-09-30 2024-09-30 Annual General Meeting NA -7.49%
2024-04-11 2024-04-11 Extraordinary General Meeting NA 4.57%
2024-04-05 2024-04-05 Extraordinary General Meeting NA -3.89%

Ortin Global Competitors Screener - Peer Stocks Comparison

Screen ORTINGLOBE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 449,803 40.80 61,674 12.69% 11,565 59.98
Divis Laboratories 295,148 87.70 11,067 13.95% 2,568 67.88
Torrent Pharmaceuticals 177,704 85.00 13,886 20.34% 2,138 49.31
Laurus Labs 121,484 89.90 6,868 22.01% 890 49.19
Zydus Life Science 120,020 27.60 27,658 17.64% 5,026 52.87
Dr Reddys Laboratories 114,718 41.80 35,059 3.90% 4,158 69.34
Cipla 112,624 39.50 29,045 2.24% 3,870 55.82
Mankind Pharma 108,866 47.90 14,636 14.85% 1,938 63.62
Aurobindo Pharma 104,063 25.80 34,145 5.56% 3,503 60.38
Lupin 89,995 17.30 29,039 26.75% 5,356 44.23

Ortin Global Company Announcements - News & Reports Screener

Screen ORTINGLOBE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 14, 2026.

The next most recent announcements are dated November 14, 2026 and November 14, 2026.

Date Update Actions
2026-11-14 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-11-14 Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors -
2026-11-14 Board Meeting Outcome for Outcome Of Board Meeting Held On 11.11.2026 -
2026-11-14 Results- Financial Results For Quarter And Half-Year Ended 30.09.2026 -
2026-11-05 Board Meeting Intimation for Meeting To Be Held On 11.11.2026. -
2026-10-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-22 Closure of Trading Window -
2026-09-08 Reg. 34 (1) Annual Report. -
2026-09-08 Notice Of AGM For The FY 2025-26 Scheduled To Be Held On 30.09.2026 -
2026-09-08 Resignation Letter -
2026-09-07 Announcement under Regulation 30 (LODR)-Change in Management -
2026-09-07 Board Meeting Outcome for Outcome Of Board Meeting -
2026-08-14 Board Meeting Outcome for Outcome Of Board Meeting Held On 14.08.2026 -
2026-08-14 Unaudited Financial Results For The Quarter Ended 30.06.2026 -
2026-08-07 Board Meeting Intimation for Meeting To Be Held On 14.08.2026 -
2026-07-11 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-11 Post-Offer Advertisement -
2026-06-24 Closure of Trading Window -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹13.00, within a 52-week range of ₹11.55 to ₹19.92. The P/E ratio is -15.20 and the P/B ratio is 16.12, with earnings per unit of ₹-0.91. Market capitalisation stands at ₹10.41 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 2 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.